GOTTO, Geoffrey et al. Real-world evidence in patient-reported outcomes (PROs) of metastatic castrate-resistant prostate cancer (mCRPC) patients treated with abiraterone acetate + prednisone (AA+P) across Canada: Final results of COSMiC. Canadian Urological Association Journal, [S. l.], v. 14, n. 12, p. E616–20, 2020. DOI: 10.5489/cuaj.6388. Disponível em: https://cuaj.ca/index.php/journal/article/view/6388. Acesso em: 29 apr. 2026.